Skip to main content

AbCellera Biologics Inc 10-Q for FY2021 Q2

AbCellera Biologics Inc. (ABCL)

10-Q 2021-08-13 For: 2021-06-30
View Original
Added on April 08, 2026

About this 10-Q

AbCellera Biologics Inc filed this 10-Q on August 13, 2021, covering the quarter ended June 30, 2021 (FY2021 Q2).

Headline figures

Quarter ended June 30, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$27.64M
up 146.2% from $11.23M a year earlier
Net loss
$2.32M
compared with net income of $6.7M a year earlier
Diluted EPS
-$0.01
compared with $0.03 a year earlier